Evan Lipson, MD, an associate professor of oncology at John Hopkins School of Medicine and a head and neck oncologist at John Hopkins Medicine, discusses feedback he’s received from colleagues at Case ...
A recent analysis suggested improved survival for women screened for breast cancer at ages 40-49, whereas draft guidelines state the harms could outweigh the benefits.